Mark Velangi
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Iron Metabolism and Disorders
- Hematopoietic Stem Cell Transplantation
- Genetics top 10%
- Hemoglobinopathies and Related Disorders
- Blood disorders and treatments
Papers in
-
- Iron Metabolism and Disorders 3
- Acute Myeloid Leukemia Research 2
- Multiple Myeloma Research and Treatments 2
- Genetics 5
- Hemoglobinopathies and Related Disorders 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Co-authors
- Amanda J. Walne (1 shared paper)Inderjeet Dokal (1 shared paper)Aloysius Ho (1 shared paper)Michael Kirwan (1 shared paper)Upal Hossain (1 shared paper)Tom Vulliamy (1 shared paper)Vincent Plagnol (1 shared paper)Shivan Pancham (3 shared papers)
- Journals
- British Journal of Haematology (2 papers)Haemophilia (1 paper)Carcinogenesis (1 paper)Genes Chromosomes and Cancer (1 paper)BMJ Open (1 paper)
- Partner nations
- United KingdomUnited StatesSingapore
In The Last Decade
Mark Velangi
17 papers receiving 254 citations
Peers
Comparison fields: 5 of 37
- Hematology 146
- Genetics 69
- Oncology 33
- Pathology and Forensic Medicine 21
- Genetics 34
Countries citing papers authored by Mark Velangi
This map shows the geographic impact of Mark Velangi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Velangi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Velangi more than expected).
Fields of papers citing papers by Mark Velangi
This network shows the impact of papers produced by Mark Velangi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Velangi. The network helps show where Mark Velangi may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Velangi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 72 | |
| 2 | 2013 | 33 | |
| 3 | 2021 | 29 | |
| 4 | 2004 | 26 | |
| 5 | 2021 | 17 | |
| 6 | 2005 | 16 | |
| 7 | 2006 | 12 | |
| 8 | 2012 | 12 | |
| 9 | 2019 | 8 | |
| 10 | 2011 | 7 | |
| 11 | 2002 | 7 | |
| 12 | 2023 | 5 | |
| 13 | 2015 | 5 | |
| 14 | 2005 | 3 | |
| 15 | 2007 | 3 | |
| 16 | 2024 | 1 | |
| 17 | 2019 | 1 |
About Mark Velangi
Mark Velangi is a scholar working on Hematology, Genetics, Molecular Biology, Cancer Research and Pathology and Forensic Medicine, having authored 17 papers that have together received 257 indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (4 papers), Iron Metabolism and Disorders (3 papers), Acute Myeloid Leukemia Research (2 papers), Cancer Genomics and Diagnostics (2 papers), Multiple Myeloma Research and Treatments (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Genetic factors in colorectal cancer (2 papers) and Bone and Joint Diseases (1 paper). The work is most often cited by research in Hematology (146 citations), Genetics (69 citations), Oncology (33 citations), Pathology and Forensic Medicine (21 citations) and Genetics (34 citations). Mark Velangi has collaborated with scholars based in United Kingdom, United States and Singapore. Frequent co-authors include Amanda J. Walne, Inderjeet Dokal, Aloysius Ho, Michael Kirwan, Upal Hossain, Tom Vulliamy, Vincent Plagnol, Shivan Pancham, Farrukh Shah and Banu Kaya. Their work appears in journals such as British Journal of Haematology, Haemophilia, Carcinogenesis, Genes Chromosomes and Cancer and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.